Cystic Fibrosis Therapeutics Market: Globally Projected to Reach by Remarkable CAGR by 2024
Precisemarketreports.com adds new report Cystic Fibrosis Therapeutics Market (By Major Marketed Products, Pharmacological Class, & Geography) and Pipeline Analysis Global Forecast to 2024 which contains global key players survey information and forec
(EMAILWIRE.COM, December 05, 2017 ) Overview of the Cystic Fibrosis Therapeutics Market:
The report spread across 121 pages is an overview of the Cystic Fibrosis Therapeutics Market (By Major Marketed Products, Pharmacological Class, & Geography) and Pipeline Analysis Global Forecast to 2024. The market for Cystic Fibrosis Therapeutics is anticipated to grow with double digit CAGR during the forecasting period. Cystic fibrosis is among the most common life-threatening genetic disorders worldwide. It is caused by defects in a single gene known as the cystic fibrosis transmembrane conductance regulator, or CFTR. The increasing prevalence of cystic fibrosis, rising awareness about cystic fibrosis therapy, strong pipeline candidates, technological advancement and high rate of R&D initiatives are some of the major factors that are driving cystic fibrosis therapeutics market. However, high cost involved in treatment, increase in complexity of disease are restraining the cystic fibrosis therapeutics market.
Get a Sample Copy of this Report @
https://www.precisemarketreports.com/report/sample/pmr-106491 .
Key Highlights of the Report:
United States dominates the global market for cystic fibrosis therapeutics.
The EU5 countries together accounted for over 20% share of the global cystic fibrosis market in 2016.
In Asian region, the prevalence of Cystic Fibrosis is observed to be very low in countries like China, India and Japan.
On the basis of pharmacological class, the CFTR modulator captures highest share of the total CF therapeutics market in 2016.
Cystic Fibrosis patients who have reduced the levels of digestive enzymes due to improper functioning of pancreas, are treated by PERT to replace these enzymes.
Italy has followed Ireland and other EU countries such as Germany, Austria, Denmark and Luxembourg in approving Orkambi for patients with CF.
It's estimated that 1 in every 2,500 babies born in the UK has cystic fibrosis.
The revenues for Creon increased 22 percent in 2015, driven primarily by continued market growth.
Zenpep sales surpassed US$ 200 Million mark in 2016.
Some of the drugs that are under clinical studies are Tezacaftor (VX-661) + ivacaftor, VX-445 + tezacaftor + ivacaftor, VX-659 + tezacaftor + ivacaftor, PTI-428, AZD5634, QR-010 and POL6014 among many others.
To Purchase this report visit @
https://www.precisemarketreports.com/paypal/checkout/pmr-106491 .
The research report Cystic Fibrosis Therapeutics Market (By Major Marketed Products, Pharmacological Class, & Geography) and Pipeline Analysis Global Forecast to 2024 provides a comprehensive assessment of the Cystic Fibrosis Therapeutics Market.
Cystic Fibrosis Company Profiles, Approved & Pipeline Product Analysis:
1. Genentech, Inc. (A Member of the Roche Group)
2. Novartis
3. Gilead Sciences, Inc.
4. Vertex Pharmaceuticals Incorporated
5. AbbVie
6. GlaxoSmithKline
7. Johnson & Johnson
8. Allergan plc
9. Pharmaxis Ltd
10. Mylan N.V
This 121 Page report with 53 Figures and 6 Tables has been studied from 8 View Points:
1. Global Cystic Fibrosis Therapeutics Market & Forecast (2014 2024)
2. Global Cystic Fibrosis Therapeutics Market - Major Marketed Products Sales & Forecast (2012 - 2024)
3. Global Cystic Fibrosis Therapeutics Market - Pharmacological Class Sales & Forecast (2015 2021)
4. By Geography - Cystic Fibrosis Therapeutics Market (2014 2024)
5. Global Cystic Fibrosis Pipeline Product Analysis By Company & Phase of Development
6. Cystic Fibrosis Company Profiles, Approved & Pipeline Product Analysis
7. Global Cystic Fibrosis Market - Industry Trends & Developments
8. Global Cystic Fibrosis Market - Growth Drivers & Challenges
To know more click here ->
https://www.precisemarketreports.com/report/enquiry/pmr-106491 .
About us:
Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario.
Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
Contact us:
Precise Market Reports
Office No. 48, Akshya Complex, Dhole Patil road,
Maharashtra, Pune 411001
India.
sales@precisemarketreports.com
+1 (323) 744 6588
https://www.precisemarketreports.com
The report spread across 121 pages is an overview of the Cystic Fibrosis Therapeutics Market (By Major Marketed Products, Pharmacological Class, & Geography) and Pipeline Analysis Global Forecast to 2024. The market for Cystic Fibrosis Therapeutics is anticipated to grow with double digit CAGR during the forecasting period. Cystic fibrosis is among the most common life-threatening genetic disorders worldwide. It is caused by defects in a single gene known as the cystic fibrosis transmembrane conductance regulator, or CFTR. The increasing prevalence of cystic fibrosis, rising awareness about cystic fibrosis therapy, strong pipeline candidates, technological advancement and high rate of R&D initiatives are some of the major factors that are driving cystic fibrosis therapeutics market. However, high cost involved in treatment, increase in complexity of disease are restraining the cystic fibrosis therapeutics market.
Get a Sample Copy of this Report @
https://www.precisemarketreports.com/report/sample/pmr-106491 .
Key Highlights of the Report:
United States dominates the global market for cystic fibrosis therapeutics.
The EU5 countries together accounted for over 20% share of the global cystic fibrosis market in 2016.
In Asian region, the prevalence of Cystic Fibrosis is observed to be very low in countries like China, India and Japan.
On the basis of pharmacological class, the CFTR modulator captures highest share of the total CF therapeutics market in 2016.
Cystic Fibrosis patients who have reduced the levels of digestive enzymes due to improper functioning of pancreas, are treated by PERT to replace these enzymes.
Italy has followed Ireland and other EU countries such as Germany, Austria, Denmark and Luxembourg in approving Orkambi for patients with CF.
It's estimated that 1 in every 2,500 babies born in the UK has cystic fibrosis.
The revenues for Creon increased 22 percent in 2015, driven primarily by continued market growth.
Zenpep sales surpassed US$ 200 Million mark in 2016.
Some of the drugs that are under clinical studies are Tezacaftor (VX-661) + ivacaftor, VX-445 + tezacaftor + ivacaftor, VX-659 + tezacaftor + ivacaftor, PTI-428, AZD5634, QR-010 and POL6014 among many others.
To Purchase this report visit @
https://www.precisemarketreports.com/paypal/checkout/pmr-106491 .
The research report Cystic Fibrosis Therapeutics Market (By Major Marketed Products, Pharmacological Class, & Geography) and Pipeline Analysis Global Forecast to 2024 provides a comprehensive assessment of the Cystic Fibrosis Therapeutics Market.
Cystic Fibrosis Company Profiles, Approved & Pipeline Product Analysis:
1. Genentech, Inc. (A Member of the Roche Group)
2. Novartis
3. Gilead Sciences, Inc.
4. Vertex Pharmaceuticals Incorporated
5. AbbVie
6. GlaxoSmithKline
7. Johnson & Johnson
8. Allergan plc
9. Pharmaxis Ltd
10. Mylan N.V
This 121 Page report with 53 Figures and 6 Tables has been studied from 8 View Points:
1. Global Cystic Fibrosis Therapeutics Market & Forecast (2014 2024)
2. Global Cystic Fibrosis Therapeutics Market - Major Marketed Products Sales & Forecast (2012 - 2024)
3. Global Cystic Fibrosis Therapeutics Market - Pharmacological Class Sales & Forecast (2015 2021)
4. By Geography - Cystic Fibrosis Therapeutics Market (2014 2024)
5. Global Cystic Fibrosis Pipeline Product Analysis By Company & Phase of Development
6. Cystic Fibrosis Company Profiles, Approved & Pipeline Product Analysis
7. Global Cystic Fibrosis Market - Industry Trends & Developments
8. Global Cystic Fibrosis Market - Growth Drivers & Challenges
To know more click here ->
https://www.precisemarketreports.com/report/enquiry/pmr-106491 .
About us:
Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario.
Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
Contact us:
Precise Market Reports
Office No. 48, Akshya Complex, Dhole Patil road,
Maharashtra, Pune 411001
India.
sales@precisemarketreports.com
+1 (323) 744 6588
https://www.precisemarketreports.com
Contact Information:
Precise Market Reports
Parag Pingale
Tel: +1 (323) 744 6588
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Precise Market Reports
Parag Pingale
Tel: +1 (323) 744 6588
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results